Emera Inc. stock rises Thursday, still underperforms market
Emera Inc. closed 0.7% below its 52-week high of C$56.33, which the company achieved on February 3rd.
Global Artificial Kidney Market to Show Positive Growth at a CAGR of ~13% by 2032 | DelveInsight
The increasing prevalence of kidney failure and end-stage renal disease, along with a growing incidence of risk factors like ...
Medicenna Reports Third Quarter Fiscal 2025 Financial and Operational Results and Provides Anticipated Milestones
Disease control rate (DCR) of 78% (7 of 9) in combination escalation arm of MDNA11 with Merck’s (known as MSD outside of Canada and the US) ...
ImmunityBio announces UK acceptance of Anktiva marketing application
ImmunityBio (IBRX) announced the Medicines and Healthcare products Regulatory Agency has validated and accepted the marketing authorization ...
Vial Adaptors for Reconstitution Drug Market to Reach USD 4,146.27 by 2032, Growing at a 7.24% CAGR - Credence Research
The Global Vial Adaptors for Reconstitution Drug Market is poised for substantial growth, reflecting strong financial ...
Mastering Pharmaceutical Document Management and Strategies for Compliance and Efficiency (ONLINE EVENT: March 4-6, 2025)
The "Mastering Pharmaceutical Document Management: Strategies for Compliance and Efficiency" training has been added to ResearchAndMarkets.com's offering. This specialized course offers a deep dive ...
Credence Research Inc.: Vial Adaptors for Reconstitution Drug Market to Reach USD 4,146.27 by 2032, Growing at a 7.24% CAGR - Credence Research
The Global Vial Adaptors for Reconstitution Drug Market is poised for substantial growth, reflecting strong financial projections and industry expansion.